Phase II, Randomized, Double-Blind, Placebo-Controlled Studies of Ruprintrivir Nasal Spray 2-Percent Suspension for Prevention and Treatment of Experimentally Induced Rhinovirus Colds in Healthy Volunteers

Human rhinovirus (HRV) infections are usually self-limited but may be associated with serious consequences, particularly in those with asthma and chronic respiratory disease. Effective antiviral agents are needed for preventing and treating HRV illnesses. Ruprintrivir (Agouron Pharmaceuticals, Inc.,...

Descrición completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Principais autores:	Hayden, Frederick G., Turner, Ronald B., Gwaltney, Jack M., Chi-Burris, Kathy, Gersten, Merril, Hsyu, Poe, Patick, Amy K., Smith, George J., Zalman, Leora S.
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 2003
Assuntos:	Antiviral Agents
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC296196/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14638501/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.12.3907-3916.2003
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!